{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:58:32Z","timestamp":1791284312176,"version":"4.1.0"},"reference-count":95,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:p>Guillain-Barr\u00e9 syndrome (GBS) is a leading cause of acquired acute neuromuscular paralysis and is an immune-mediated disorder of the peripheral nervous system (PNS). Accumulating evidence indi-cates that GBS is often preceded by infectious events that trigger autoimmune responses through mechanisms such as molecular mimicry and autoantibody production. Campylobacter jejuni remains the most common bacterial agent, but viral pathogens also contribute to the development of GBS. This review summarizes the current evidence regarding viruses as triggers of GBS, including herpes-viruses, hepatotropic viruses (A, B, C, and E), human immunodeficiency virus, Zika virus, influenza virus, varicella-zoster virus, and the coronavirus SARS-CoV-2. Emphasis is placed on laboratory test results related to viral GBS, including antiganglioside antibodies, serological markers of recent in-fection, molecular diagnostic methods, and cerebrospinal fluid analysis. From the standpoint of la-boratory medicine, both the clinical diagnosis and the distinction of GBS subtypes can be supported by the identification of recent viral infections and the detection of immunological biomarkers. How-ever, cross-reactivity, extended antibody persistence, and inadequate assay standardization frequently make it difficult to interpret laboratory test results. In patients with probable viral GBS, this review shows the diagnostic significance and limitations of routine laboratory testing. It also highlights the significance of close coordination between laboratory professionals and clinicians.<\/jats:p>","DOI":"10.11613\/bm.2026.030502","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:05:51Z","timestamp":1790931951000},"page":"431-444","source":"Crossref","is-referenced-by-count":0,"title":["Viral triggers of Guillain-Barr\u00e9 syndrome"],"prefix":"10.11613","volume":"36","author":[{"given":"Karolina","family":"K\u0142odnicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Januszewski","sequence":"additional","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Po-land; Doctoral School, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Tyczy\u0144ska","sequence":"additional","affiliation":[{"name":"Doctoral School, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Teresi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Po-land"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Trzaskacz","sequence":"additional","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Forma","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Flieger","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Baj","sequence":"additional","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4885","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"key20261002090547_r1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"key20261002090547_r2","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"key20261002090547_r3","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1128\/IAI.00967-06","article-title":"Ganglioside molecular mimicry and its pathological roles in Guil-lain-Barr\u00e9 syndrome and related diseases.","volume":"74","author":"Yu","year":"2006","journal-title":"Infect Immun"},{"key":"key20261002090547_r4","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.875","article-title":"COVID-19 as a trigger of Guillain-Barr\u00e9 syndrome: A review of the molecular mechanism.","volume":"11","author":"Malekpour","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"key20261002090547_r5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"key20261002090547_r6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.644664","article-title":"Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms.","volume":"12","author":"Verzosa","year":"2021","journal-title":"Front Immunol"},{"key":"key20261002090547_r7","article-title":"A Rare Association Between Herpes Simplex Virus Type 1 and Miller-Fisher Syndrome.","volume":"15","author":"Bies","year":"2023","journal-title":"Cureus"},{"key":"key20261002090547_r8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.it.2022.02.003","article-title":"Guillain-Barr\u00e9 syndrome: expanding the con-cept of molecular mimicry.","volume":"43","author":"Laman","year":"2022","journal-title":"Trends Immunol"},{"key":"key20261002090547_r9","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241297086","article-title":"A rare association of Guillain-Barr\u00e9 syndrome\/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?","volume":"17","author":"Alberti","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"key20261002090547_r10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/jvi.61.4.1125-1135.1987","article-title":"Antigenic cross-reactions among herpes sim-plex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus.","volume":"61","author":"Balachandran","year":"1987","journal-title":"J Virol"},{"key":"key20261002090547_r11","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241297086","article-title":"A rare association of Guillain-Barr\u00e9 syndrome\/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?","volume":"17","author":"Alberti","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"key20261002090547_r12","article-title":"Exploring Treatments for a Rare Guillain-Barr\u00e9 Variant: A Case Report of Miller-Fisher Syndrome.","volume":"16","author":"Diggikar","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"key20261002090547_r13","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/molecules26041132","article-title":"Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.","volume":"26","author":"Andrei","year":"2021","journal-title":"Molecules"},{"key":"key20261002090547_r14","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1097\/MS9.0000000000001370","article-title":"Guillain-Barr\u00e9 syndrome following varicella-zoster virus infection: a case report and systematic review.","volume":"85","author":"Nerabani","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"key20261002090547_r15","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1042\/BST20190511","article-title":"Varicella-zoster virus: molecular controls of cell fu-sion-dependent pathogenesis.","volume":"48","author":"Oliver","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"key20261002090547_r16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0196-6553(87)90164-7","article-title":"Cytomegalovirus: epidemiology and infection control.","volume":"15","author":"Pomeroy","year":"1987","journal-title":"Am J Infect Control"},{"key":"key20261002090547_r17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpn.2015.11.004","article-title":"CMV-associated axonal sensory-motor Guillain-Barr\u00e9 syndrome in a child: Case report and review of the literature.","volume":"20","author":"Spagnoli","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"key20261002090547_r18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/cmi.2017.142","article-title":"Guillain\u2013Barr\u00e9 syndrome, transverse myelitis and infectious diseases.","volume":"15","author":"Rodr\u00edguez","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"key20261002090547_r19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jnnp.66.3.376","article-title":"Antiganglioside antibod-ies in Guillain-Barr\u00e9 syndrome after a recent cytomegalovirus infection.","volume":"66","author":"Khalili-Shirazi","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20261002090547_r20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0009922819898186","article-title":"Guillain-Barr\u00e9 Syn-drome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review.","volume":"59","author":"Silva","year":"2020","journal-title":"Clin Pediatr (Phila)"},{"key":"key20261002090547_r21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cir074","article-title":"Guillain-Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study.","volume":"52","author":"Orlikowski","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key20261002090547_r22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3904\/kjim.2015.033","article-title":"Mild form of Guillain-Barr\u00e9 syndrome in a patient with primary Epstein-Barr virus infection.","volume":"31","author":"Kim","year":"2016","journal-title":"Korean J Intern Med"},{"key":"key20261002090547_r23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.12659\/AOT.883468","article-title":"Guil-lain-Barr\u00e9 syndrome in the course of EBV infection after kidney transplantation--a case report.","volume":"17","author":"Masajtis-Zagajewska","year":"2012","journal-title":"Ann Transplant"},{"key":"key20261002090547_r24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ana.410090709","article-title":"Role of infection in Guillain-Barr\u00e9 syndrome: laboratory confirma-tion of herpesviruses in 41 cases.","volume":"9","author":"Dowling","year":"1981","journal-title":"Ann Neurol"},{"key":"key20261002090547_r25","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s12031-020-01767-6","article-title":"Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.","volume":"71","author":"Jha","year":"2021","journal-title":"J Mol Neurosci"},{"key":"key20261002090547_r26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117263","article-title":"Guillain Barr\u00e9 Syn-drome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series.","volume":"420","author":"Sriwastava","year":"2021","journal-title":"J Neurol Sci"},{"key":"key20261002090547_r27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neurol.2020.10.001","article-title":"Neurological manifesta-tions associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.","volume":"177","author":"Maury","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"key20261002090547_r28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105715","article-title":"Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection.","volume":"168","author":"Savelieff","year":"2022","journal-title":"Neurobiol Dis"},{"key":"key20261002090547_r29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/cjn.2021.102","article-title":"Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.","volume":"49","author":"Aladawi","year":"2022","journal-title":"Can J Neurol Sci"},{"key":"key20261002090547_r30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10072-020-04553-9","article-title":"Is Guillain-Barr\u00e8 syn-drome triggered by SARS-CoV-2? Case report and literature review.","volume":"42","author":"Agosti","year":"2021","journal-title":"Neurol Sci"},{"key":"key20261002090547_r31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00415-020-09911-3","article-title":"Guillain-Barr\u00e9 syn-drome in the COVID-19 era: just an occasional cluster?","volume":"268","author":"Gigli","year":"2021","journal-title":"J Neurol"},{"key":"key20261002090547_r32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2018.1058","article-title":"Clin-ical Features of Guillain-Barr\u00e9 Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016.","volume":"75","author":"Dirlikov","year":"2018","journal-title":"JAMA Neurol"},{"key":"key20261002090547_r33","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaneurol.2017.1703","article-title":"Neurologic Complications Associated With the Zika Virus in Brazilian Adults.","volume":"74","author":"da Silva","year":"2017","journal-title":"JAMA Neurol"},{"key":"key20261002090547_r34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guil-lain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"key20261002090547_r35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0045-2018","article-title":"Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.","volume":"7","author":"Cunningham","year":"2019","journal-title":"Microbiol Spectr"},{"key":"key20261002090547_r36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases.","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"key20261002090547_r37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-immunol-020711-075041","article-title":"Brain-reactive antibodies and dis-ease.","volume":"31","author":"Diamond","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"key20261002090547_r38","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16346","article-title":"Guillain-Barr\u00e9 syndrome: History, pathogenesis, treatment, and future direc-tions.","volume":"31","author":"Hughes","year":"2024","journal-title":"Eur J Neurol"},{"key":"key20261002090547_r39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-015-0047-0","article-title":"Risk of Guillain-Barr\u00e9 syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwe-gian population-based cohort study.","volume":"31","author":"Ghaderi","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"key20261002090547_r40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/vaccines8030431","article-title":"Incidence of Guillain-Barr\u00e9 Syndrome Is Not Associated with Influenza Vaccination in the Elderly.","volume":"8","author":"Lee","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"key20261002090547_r41","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.14030","article-title":"Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature Review of the Last 20 Years.","volume":"32","author":"Andani","year":"2025","journal-title":"J Viral Hepat"},{"key":"key20261002090547_r42","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","article-title":"From hepatitis A to E: A critical review of viral hepatitis.","volume":"27","author":"Castaneda","year":"2021","journal-title":"World J Gastroenterol"},{"key":"key20261002090547_r43","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.7254","article-title":"HAV-induced acalculous cholecystitis: A case report and literature review.","volume":"11","author":"Salajegheh","year":"2023","journal-title":"Clin Case Rep"},{"key":"key20261002090547_r44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.31645","article-title":"Factors Associated With Hepatitis A Mortality During Person-to-Person Outbreaks: A Matched Case-Control Study-United States, 2016-2019.","volume":"74","author":"Hofmeister","year":"2021","journal-title":"Hepatology"},{"key":"key20261002090547_r45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development.","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"key20261002090547_r46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1258\/004947506778604706","article-title":"An unusual presentation of hepatitis A virus infection: Guillain-Barr\u00e9 syndrome.","volume":"36","author":"Kadanali","year":"2006","journal-title":"Trop Doct"},{"key":"key20261002090547_r47","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.588290","article-title":"Trauma-Related Guillain-Barr\u00e9 Syndrome: Sys-tematic Review of an Emerging Concept.","volume":"11","author":"Huang","year":"2020","journal-title":"Front Neurol"},{"key":"key20261002090547_r48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 Syndrome and Variants.","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"key":"key20261002090547_r49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2025.100551","article-title":"Is there a link between Hepatitis A virus and Guillain-Barr\u00e9 syndrome? A systematic review of case reports.","volume":"38","author":"Ghasemi","year":"2025","journal-title":"eNeurologicalSci"},{"key":"key20261002090547_r50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps.","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"key20261002090547_r51","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007077","article-title":"Unilateral facial palsy in Guillain-Barre syndrome (GBS): a rare occurrence.","volume":"2012","author":"Verma","year":"2012","journal-title":"BMJ Case Rep"},{"key":"key20261002090547_r52","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2169\/internalmedicine.33.799","article-title":"Guillain-Barr\u00e9 syndrome following fulminant viral hepatitis A.","volume":"33","author":"Ono","year":"1994","journal-title":"Intern Med"},{"key":"key20261002090547_r53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jmv.20656","article-title":"Case report: Hepatitis A preced-ing Guillain-Barr\u00e9 syndrome.","volume":"78","author":"Chitambar","year":"2006","journal-title":"J Med Virol"},{"key":"key20261002090547_r54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry.","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"key20261002090547_r55","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/microorganisms11051140","article-title":"Vertical Transmission of Hepatitis B Virus-An Update.","volume":"11","author":"di Filippo Villa","year":"2023","journal-title":"Microorganisms"},{"key":"key20261002090547_r56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3748\/wjg.v30.i10.1295","article-title":"Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies.","volume":"30","author":"Ma","year":"2024","journal-title":"World J Gastroenterol"},{"key":"key20261002090547_r57","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"key20261002090547_r58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12967-024-05704-8","article-title":"Explore genetic susceptibility associ-ation between viral infections and Guillain-Barr\u00e9 syndrome risk using two-sample Mendelian ran-domization.","volume":"22","author":"Kong","year":"2024","journal-title":"J Transl Med"},{"key":"key20261002090547_r59","first-page":"121","article-title":"A rare case of acute hepatitis B virus infec-tion causing guillain-barr\u00e9 syndrome.","volume":"9","author":"Yimam","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key20261002090547_r60","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-019-00596-1","article-title":"Vaccines and the risk of Guillain-Barr\u00e9 syndrome.","volume":"35","author":"Chen","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"key20261002090547_r61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-444-52001-2.00004-2","article-title":"Demyelination in multiple sclerosis.","volume":"122","author":"Lubetzki","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"key20261002090547_r62","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027989","article-title":"Severe Guillain-Barr\u00e9 syndrome associated with chronic hepatitis B: A case report and literature review.","volume":"100","author":"Wei","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"key20261002090547_r63","first-page":"491","article-title":"The immunology of inflammatory demyelinating dis-ease. McAlpine\u2019s.","author":"Wekerle","year":"2006","journal-title":"Mult Scler"},{"key":"key20261002090547_r64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41983-024-00820-0","article-title":"Guillain\u2013Barre syndrome: small-volume plasmapheresis versus intravenous immunoglobulin - 3rd level hospital experience.","volume":"60","author":"Balili","year":"2024","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"key20261002090547_r65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biomedicines11020271","article-title":"Virus-Lipid Interplay: Pathogene-sis and Clinical Impact.","volume":"11","author":"Elgretli","year":"2023","journal-title":"Biomedicines"},{"key":"key20261002090547_r66","article-title":"Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barr\u00e9 Syndrome.","volume":"11","author":"Molokwu","year":"2019","journal-title":"Cureus"},{"key":"key20261002090547_r67","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2019.06.029","article-title":"TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor au-toantibody responses.","volume":"71","author":"Comarmond","year":"2019","journal-title":"J Hepatol"},{"key":"key20261002090547_r68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"NATURAL HISTORY OF HEPATITIS C.","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"key20261002090547_r69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guil-lain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis.","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"key20261002090547_r70","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"key":"key20261002090547_r71","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41598-020-58768-z","article-title":"Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection.","volume":"10","author":"Gorin","year":"2020","journal-title":"Sci Rep"},{"key":"key20261002090547_r72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection.","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"key":"key20261002090547_r73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12879-018-2959-2","article-title":"Guillain-Barre syndrome caused by hepatitis E infec-tion: case report and literature review.","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key20261002090547_r74","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"key20261002090547_r75","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","article-title":"GM1\/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"key20261002090547_r76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/187152706777950765","article-title":"Ganglioside mimicry as a cause of Guillain-Barr\u00e9 syndrome.","volume":"5","author":"Komagamine","year":"2006","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"key20261002090547_r77","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3760\/cma.j.issn.0366-6999.20131338","article-title":"HIV seroconver-sion manifesting as Guillian-Barre syndrome.","volume":"127","author":"Varshney","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"key20261002090547_r78","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/00002030-200207260-00017","article-title":"Acute Guillain-Barr\u00e9 syndrome during the chronic phase of HIV infection and dramatic improvement under highly active an-tiretroviral therapy.","volume":"16","author":"Bani-Sadr","year":"2002","journal-title":"AIDS"},{"key":"key20261002090547_r79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rehab.2011.09.009","article-title":"Functional recovery of untreated human immu-nodeficiency virus-associated Guillain-Barr\u00e9 syndrome: a case report.","volume":"54","author":"Schreiber","year":"2011","journal-title":"Ann Phys Rehabil Med"},{"key":"key20261002090547_r80","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4314\/njm.v19i4.61967","article-title":"Profile of neurological admis-sions at the University of Nigeria Teaching Hospital Enugu.","volume":"19","author":"Ekenze","year":"2010","journal-title":"Niger J Med"},{"key":"key20261002090547_r81","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/01.CCM.0000069516.81522.F4","article-title":"Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barr\u00e9 syndrome.","volume":"31","author":"Schleicher","year":"2003","journal-title":"Crit Care Med"},{"key":"key20261002090547_r82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.0000000000002837","article-title":"Neurologic signs and symptoms frequently manifest in acute HIV infection.","volume":"87","author":"Hellmuth","year":"2016","journal-title":"Neurology"},{"key":"key20261002090547_r83","article-title":"Refractory HIV-Associated Guillain-Barr\u00e9 Syndrome Responsive to Antiretroviral Therapy: A Case Report.","volume":"2024","author":"Coyle","year":"2024","journal-title":"Case Rep Infect Dis"},{"key":"key20261002090547_r84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2022.102368","article-title":"Guillain-Barr\u00e9 syndrome spectrum as manifestation of HIV-related immune reconstitution inflammatory syndrome: case report and literature review.","volume":"26","author":"Vidal","year":"2022","journal-title":"Braz J Infect Dis"},{"key":"key20261002090547_r85","article-title":"Guillain-Barr\u00e9 Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report.","volume":"2011","author":"Pontali","year":"2011","journal-title":"Case Rep Infect Dis"},{"key":"key20261002090547_r86","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clinph.2012.05.022","article-title":"Poly-neuropathy induced by HIV disease and antiretroviral therapy.","volume":"124","author":"Kokotis","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"key20261002090547_r87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1.","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"key20261002090547_r88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/cells13080672","article-title":"HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium.","volume":"13","author":"Kanmogne","year":"2024","journal-title":"Cells"},{"key":"key20261002090547_r89","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2005.05.198","article-title":"Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins.","volume":"333","author":"Kanmogne","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20261002090547_r90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-444-64012-3.00006-X","article-title":"Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection.","volume":"165","author":"Cysique","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"key20261002090547_r91","first-page":"127","article-title":"Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease.","volume":"36","author":"Bernelli","year":"2020","journal-title":"Can J Cardiol"},{"key":"key20261002090547_r92","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/09540121.2020.1758614","article-title":"Primary lung cancer diagnoses in people living with HIV in a large clinical centre in Montreal, Canada over 3 decades.","volume":"32","author":"Bichara","year":"2020","journal-title":"AIDS Care"},{"key":"key20261002090547_r93","doi-asserted-by":"crossref","DOI":"10.1099\/jmmcr.0.005107","article-title":"HIV positive patient with GBS-like syn-drome.","volume":"4","author":"Shepherd","year":"2017","journal-title":"JMM Case Rep"},{"key":"key20261002090547_r94","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/1752-1947-5-563","article-title":"Guil-lain-Barre syndrome presenting with sensory disturbance following a herpes virus infection: a case report.","volume":"5","author":"Ntziora","year":"2011","journal-title":"J Med Case Rep"},{"key":"key20261002090547_r95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12883-024-03607-1","article-title":"Guillain-Barre syn-drome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report.","volume":"24","author":"Wanninayake","year":"2024","journal-title":"BMC Neurol"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/36\/3\/10.11613\/BM.2026.030502\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:48:46Z","timestamp":1791283726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/36\/3\/10.11613\/BM.2026.030502"}},"subtitle":["implications for laboratory diagnostics"],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":95,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,10,5]]},"published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2026.030502","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}